Controlled, randomized trial to evaluate efficacy of adjuvant chemotherapy between S-1 and UFT [tegafur/uracil] for locally advanced squamous cell carcinoma of the head and neck: Phase III study.

Trial Profile

Controlled, randomized trial to evaluate efficacy of adjuvant chemotherapy between S-1 and UFT [tegafur/uracil] for locally advanced squamous cell carcinoma of the head and neck: Phase III study.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Jun 2013

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Tegafur/uracil
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2013 Primary endpoint 'Disease-free-survival-rate' has not been met according to results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
    • 04 Jun 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
    • 10 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top